A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19

Mostrar otras versiones (1)

The global coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to unprecedented social and economic consequences. The risk of morbidity and mortality due to COVID-19 increases dramatically in the presence of coexisting medical...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yadi, Hou, Yuan, Shen, Jiayu, Mehra, Reena, Kallianpur, Asha, Culver, Daniel A., Gack, Michaela U., Farha, Samar, Zein, Joe, Comhair, Suzy, Fiocchi, Claudio, Stappenbeck, Thaddeus, Chan, Timothy, Eng, Charis, Jung, Jae U., Jehi, Lara, Erzurum, Serpil, Cheng, Feixiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728249/
https://www.ncbi.nlm.nih.gov/pubmed/33156843
http://dx.doi.org/10.1371/journal.pbio.3000970

Ejemplares similares

Ejemplares similares